Chemical SOP
Microbiology SOP
Warehouse SOP
Manufacturing SOP
Information technology SOP
admin

admin

Risk Assessment for GMP Drains

Risk Assessment for GMP Drain

Introduction: Drains in pharmaceutical manufacturing areas play a crucial role in managing wastewater, preventing backflow, and maintaining sanitary conditions. However, if not properly designed, maintained, or monitored, GMP (Good Manufacturing Practice) drains can become significant sources of contamination—posing a risk…

Risk Assessment for Typo Error in Pharma

Risk assessment for typo error in pharma

Typographical errors (typo errors) in the pharmaceutical industry, though often perceived as minor clerical mistakes, can lead to significant consequences affecting product quality, regulatory compliance, and patient safety. These errors may occur in a wide range of critical documents, including…

Risk Assessment for Data Integrity

Data Integrity

Data Integrity refers to the completeness, consistency, accuracy, and reliability of data throughout its lifecycle. In the pharmaceutical industry, data integrity is not just a regulatory requirement—it is the foundation of trust in pharmaceutical products. Regulatory agencies such as the…

Risk Assessment for Stability Samples not Charged

Risk Assessment for Stability Samples Not Charged

Failure to charge (place) stability samples as per the approved protocol is a significant GMP deviation that may compromise product shelf life justification and regulatory compliance. A structured risk assessment is essential to evaluate the impact and determine appropriate corrective…

Risk Assessment for AQL not performed

Risk Assessment for AQL not performed

Introduction: The Acceptable Quality Level (AQL) inspection is a critical component of the quality assurance process that determines whether a batch of product meets predefined acceptance criteria before release or further processing. Failure to perform AQL inspection can result in…

Risk Assessment for Tablet Defects in pharma

Risk Assessment for Tablets Defects in Pharma

Risk assessment for tablet defects is a critical quality tool used in pharmaceutical manufacturing to identify, evaluate, and control potential sources of failure that could impact tablet quality, patient safety, and regulatory compliance. These defects may arise due to issues…

error: Content is protected !!

This is the Premium Content

You can access this page after paying the subscription fees of 21 ₹ /month only.